The Health Law Society

The Health Law Society is the student arm of the Institute of Health Law Studies and an integral part of IHLS. HLS in conjunction with IHLS promotes the understanding of health policy issues for all those involved in healthcare, including providers, attorneys, and patients. We do this through speaker events, research, writing, and community service. Some of our recent activities are listed below. Please feel free to contact any of the officers or the IHLS main office if you have any questions or visit the HLS Student Bar Association Website here.

President: Samantha Cantilena

Vice President: Kimberly Barrientos

Secretary: Julia Goldman

Treasurer: Luis Bautista

Membership/Communications Chair: Mona Sobhani

Philanthrophic Chair: Aida Flores

Social Chair: Isabel Mansanque

Journal of Biolaw and Business

HLS edits the Recent Developments Section of the Journal of Biolaw & Business.

Editors-in-Chief: Jenna Bateman (lead editor), Julia Goldman (asst. editor)

Faculty Editor: Bryan A. Liang, MD, PhD, JD

Forthcoming Research

Bryan A. Liang, Tim Mackey, & Kimberly Lovett, Emerging Dangers from Direct Botulinum Access and Use, JOURNAL OF HOMELAND SECURITY AND EMERGENCY MANAGEMENT (2012), forthcoming.

Bryan A. Liang & Tim Mackey, FDA Current Shortage Drugs and Internet Sourcing Risks, JOURNAL OF MEDICAL INTERNET RESEARCH (2012), forthcoming.

Bryan A. Liang, Tim Mackey, & Kimberly M. Lovett, eHealth Ethics: The Online Medical Marketplace and Emerging Ethical Issues, ETHICS IN BIOLOGY, ENGINEERING & MEDICINE (2012), forthcoming.

Bryan A. Liang & Tim Mackey, Creating Illicit Laparoscopic Appendectomy Operating Rooms Using Online Sourcing, AMERICAN SURGEON (2012), forthcoming.

Kimberly M. Lovett, Bryan A. Liang, and Tim Mackey, Risks of Online Direct-to-Consumer Tumor Markers for Cancer Screening, JOURNAL OF CLINICAL ONCOLOGY (2012), forthcoming.

Bryan A. Liang & Kimberly M. Lovett, Error Disclosure and Patient Safety: Integrating Lessons and Entity Culture for Continuous System Improvement. In: Agrawal A, ed. CLINICAL CASE SERIES IN PATIENT SAFETY. New York: Springer, 2012; forthcoming.

Timothy K. Mackey, Bryan A. Liang, & Kimberly M. Lovett, DTC Sleep Apnea Screening Tests Online, JOURNAL OF CLINICAL SLEEP MEDICINE (2012), forthcoming.

Timothy K. Mackey & Bryan A. Liang, Integrating Biodiversity Management and Indigenous Biopiracy Protection to Promote Environmental Justice and Global Health, AMERICAN JOURNAL OF PUBLIC HEALTH (2012), forthcoming.

Bryan A. Liang & Timothy K. Mackey, Addressing Illicit Online Pharmacies: Global Patient Safety and Regulatory Challenges. In: COMBATING SUBSTANDARD AND COUNTERFEIT PHARMACEUTICALS: CHALLENGES, IDENTIFICATION, AND POLICY (Perry Wang & Albert Wertheimer, eds.), London: ILM Publications (2012), forthcoming.

Bryan A. Liang & Timothy K. Mackey, Preparing for Health Diplomacy Negotiations—Global Governance and the Failed Case of Taiwan, WHO, and SARS. In: Ellen Rosskam & Ilona Kickbusch, eds., NEGOTIATING AND NAVIGATING GLOBAL HEALTH: CASE STUDIES IN GLOBAL HEALTH DIPLOMACY, London: Imperial College World Scientific Press (2012), forthcoming.

Published Research

Bryan A. Liang & Timothy K. Mackey, Vaccine Shortages and Suspect Online Pharmacy Sellers, 30(2) VACCINE 103 (2012) doi:10.1016/j.vaccine.2011.11.016.

Timothy K. Mackey & Bryan A. Liang, Lessons from SARS and 2009 H1N1 influenza: Employing a WHO-WTO Forum to Promote Optimal Economic-Public Health Pandemic Response, 33(1) JOURNAL OF PUBLIC HEALTH POLICY 119 (2012).

Timothy K. Mackey & Bryan A. Liang, Off Label Promotion Reform: A Legislative Proposal Addressing Vulnerable Patient Drug Access and Inappropriate Pharmaceutical Marketing, 35(1) UNIVERSITY OF MICHIGAN JOURNAL OF LAW REFORM 1 (2011).

Kimberly M. Lovett & Bryan A. Liang, Risks of Online Advertisement of Direct-to-Consumer Thermography for Breast Cancer Screening. 11(12) NATURE REVIEWS CANCER 827 (2011) doi:10.1038/nrc3170.

Bryan A. Liang & Timothy K. Mackey, Emerging Patient Safety Issues Under Healthcare Reform: Follow On Biologics and Immunogenicity. 7 THERAPEUTICS & CLINICAL RISK MANAGEMENT 483 (2011).

Bryan A. Liang & Tim Mackey, Quality and Safety in Health Care: What Does the Future Hold? 135 ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 1425 (2011).

Tim Mackey & Bryan A. Liang, The Global Counterfeit Drug Trade: Patient Safety and Public Health Risks, 100(11) JOURNAL OF PHARMACEUTICAL SCIENCES 4571 (2011). doi: 10.1002/jps

Bryan A. Liang & Timothy K. Mackey, Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising, 13(3) JOURNAL OF MEDICAL INTERNET RESEARCH e64 (2011) doi:10.2196/jmir.1775.

Timothy K. Mackey & Bryan A. Liang, Promoting Online Drug Safety: Using Public–Private Partnerships to Deter Illicit Online Drug Sales, 17(3) JOURNAL OF COMMERCIAL BIOTECHNOLOGY 266 (2011).

Bryan A. Liang, Global Governance: Promoting Biodiversity and Protecting Indigenous Communities Against Biopiracy, 17(3) JOURNAL OF COMMERCIAL BIOTECHNOLOGY 248 (2011).

Bryan A. Liang, Public-Private Partnerships in Global Health, 17(3) JOURNAL OF COMMERCIAL BIOTECHNOLOGY 230 (2011).

Bryan A. Liang & Mark Boyd, PTSD in Returning Wounded Warriors: Ensuring Medically Appropriate Evaluation and Legal Representation Through Legislative Reform, 22(1) STANFORD LAW & POLICY REVIEW 177 (2011).

Kimberly Lovett & Bryan A. Liang, DTC cardiac testing and suspect risk evaluation. 305(24) JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2567 (2011).

Bryan A. Liang & Timothy K. Mackey, Reforming Direct-to-Consumer Advertising, 29(5) NATURE BIOTECHNOLOGY 397 (2011).

Erin Minelli & Bryan A. Liang, Transplant Candidates and Substance Use: Adopting Rational Health Policy for Resource Allocation, 44(3) UNIVERSITY OF MICHIGAN JOURNAL OF LAW REFORM 667 (2011).

Bryan A. Liang & Timothy K. Mackey, Moving from Traditional Law and Medicine To Promote Safety and Effective Risk Management. In: NURSING MALPRACTICE, 4th ed. 59-76 (Patricia Iyer & Barbara J. Levin, eds.), Tucson, AZ: Lawyers & Judges Publishing Co. (2011).

Carolyn Standley & Bryan A. Liang, Addressing Inappropriate Care Provision at the End of Life: A Policy Proposal for Hospitals, 15(1) MICHIGAN STATE UNIVERSITY JOURNAL OF MEDICINE & LAW 138-176 (2011).

Bryan A. Liang & Timothy K. Mackey, Direct to Consumer Advertising with Interactive Internet Media: Global Regulation and Public Health Issues, 305(8) JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 824 (2011).

Timothy K. Mackey & Bryan A. Liang, The Evolving Role of Practice Guidelines in Medical Malpractice Litigation, 13(1) VIRTUAL MENTOR: ETHICS JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 36 (2011).

Regina Dawson, Healthcare Reform Passes, 13(3&4) J. BIOLAW & BUS. (2010).

Robert Kradin, Talk Therapy Cost-Efficient in Insomnia Treatment, 13(3&4) J. BIOLAW & BUS. (2010).

Kim Dimino Reduction in Heart Attack and Stroke in Diabetic patients with an Inexpensive Drug Regime, 13(3&4) J. BIOLAW & BUS. (2010).

Georg Guenther Joerg Haensel, New Combination of Drug and Antidote Promises Fewer Adverse Side Effects in Anticoagulation, 13(3&4) J. BIOLAW & BUS. (2010).

Jacqueline Runner, Family Doctors Prescribing the Majority of Mental Health Drugs, 13(3&4) J. BIOLAW & BUS. (2010).

Matthew Wheeler, Comparative Effectiveness Research and FDA Labelling, 13(3&4) J. BIOLAW & BUS. (2010).

Bryan A. Liang, Costs and Benefits, 13(3&4) J. BIOLAW & BUS. (2010).

Bryan A. Liang, Supporting Pharmaceutical Diversion and Counterfeiting Prosecutions: A Role for Medical Professionals, 13(1&2) JOURNAL OF BIOLAW & BUSINESS 55 (2010).

Bryan A. Liang, Supporting Prosecution of Pharmaceutical Diversion and Counterfeiting: A Role for Medical Professionals, 13(1&2) J. BIOLAW & BUS. (2010).

Georg Guenther Joerg Haensel, Medical device approval by the FDA undergoing review, 13(1&2) J. BIOLAW & BUS. (2010).

Stephanie Capps, Protecting against illicit access to implantable medical devices, 13(1&2) J. BIOLAW & BUS. (2010).

Sasha Kamfiroozie, Potential economic and health risks: Abbreviated approval for Follow-On Biologics, 13(1&2) J. BIOLAW & BUS. (2010).

Matthew Wheeler, The questionable validity of gene patents, 13(1&2) J. BIOLAW & BUS. (2010).

Kevin Metros, Prospective solutions for the problem of regional variations in diagnostic procedures, 13(1&2) J. BIOLAW & BUS. (2010).

Robert Kradin, Economic success means healthcare challenges for China, 13(1&2) J. BIOLAW & BUS. (2010).

Bryan A. Liang, The Advent of New Technology--and Need Needs for Assessment, 13(1&2) J. BIOLAW & BUS. (2010).

Bryan A. Liang, Pharmaceutical Crime: Investigating and Prosecuting Drug Diversion and Counterfeiting, 13(1&2) JOURNAL OF BIOLAW & BUSINESS 36 (2010).

Bryan A. Liang & Tim Mackey, Addressing Institutional Conflict of Interest to Promote Patient Safety, 7(6) PATIENT SAFETY & QUALITY HEALTHCARE 36 (2010).

Matthew Wheeler, Comparative Effectiveness and FDA Labeling, 13(3&4) J. BIOLAW & BUS. (2010).

Jacqueline Runner, Family Doctors Prescribing the Majority of Mental Health Drugs, 13(3&4) J. BIOLAW & BUS. (2010).

Georg Guenther Joerg Haensel, New Combination of Drug and Antidote Promises Fewer Adverse Effects in Anticoagulation, 13(3&4) J. BIOLAW & BUS. (2010).

Kim Dimino, Reduction in Heart Attack and Stroke in Diabetic Patients with an Inexpensive Drug Regimen, 13(3&4) J. BIOLAW & BUS. (2010).

Robert Kradin, Talk Therapy Cost-Efficient in Insomnia Treatment, 13(3&4) J. BIOLAW & BUS. (2010).

Regina Dawson, Healthcare Reform Passes, 13(3&4) J. BIOLAW & BUS. (2010).

Bryan A. Liang, Costs and Benefits, 13(3&4) J. BIOLAW & BUS. (2010).

Bryan A. Liang & Tim Mackey, Confronting Conflict: Addressing Institutional Conflicts of Interest in Academic Medical Centers, 36(1) AMERICAN JOURNAL OF LAW & MEDICINE 136 (2010).

Bryan A. Liang, The Advent of New Technology—and New Needs for Assessment, 13(1&2) J. Biolaw & Bus. (2010).

Georg Guenther Joerg Haensel, Medical Device Approval by the FDA Undergoing Review, 13(1&2) J. Biolaw & Bus. (2010).

Stphanie Capps, Protecting Against Illicit Access to Implantable Medical Devices, 13(1&2) J. Biolaw & Bus. (2010).

Sasha Kamfiroozie, Potential Economic and Health Risks: Abbreviated Approval for Follow-On Biologics, 13(1&2) J. Biolaw & Bus. (2010).

Matthew Wheeler, The Questionable Validity of Gene Patents, 13(1&2) J. Biolaw & Bus. (2010).

Kevin Metros, Prospective Solutions for the Problem of Regional Variations in Diagnostic Procedures, 13(1&2) J. Biolaw & Bus. (2010).

Robert Kradin, Economic Success Means Healthcare Challenges for China, 13(1&2) J. Biolaw & Bus. (2010).

Bryan A. Liang & Tim Mackey, Consent Contraindicated? In Reply, 328(5974) SCIENCE 45 (2010).

Nicole Wells, Digitial Disease Detection: Harnessing the Web for Public Health Surveillance, 12(4) J. BIOLAW & BUS. (2009).

Steven M. Silva, Informed Consent Problems in International Clinical Trials, 12(4) J. BIOLAW & BUS. (2009).

Bradley Beherns, Medical Device Industry Weathering Economic Downturn, 12(4) J. BIOLAW & BUS. (2009).

Kevin Rhine, Adult Stem Cells Engineered to Fight Cancer, 12(4) J. BIOLAW & BUS. (2009).

Trenton G. Lamere, New Thermal Treatment Aids Asthma Sufferers, 12(4) J. BIOLAW & BUS. (2009).

Matthew Wheeler, Down Syndrome Study Shows Possible Cures for Certain Cancers, 12(4) J. BIOLAW & BUS. (2009).

Bryan A. Liang & Tim Mackey, Reforming Off-Label Promotion to Enhance Orphan Disease Treatment, 327(5963) SCIENCE 273 (2010).

Bryan A. Liang, Taking Nothing for Granted, 12(4) JOURNAL OF BIOLAW & BUSINESS 15 (2009).

Tim Mackey & Bryan A. Liang, Incentivizing “Green” Technology Transfer to Developing Countries, 12(4) JOURNAL OF BIOLAW & BUSINESS 11 (2009).

Bryan A. Liang & Tim Mackey, Searching for Safety: A Reply to Cooperman and Levitt, 35(4) AMERICAN JOURNAL OF LAW & MEDICINE 687 (2009).

Bryan A. Liang, Promise and Potential, 12(2) J. BIOLAW & BUS. (2009).

Matthew Wheeler, Antibiotic Resistant Bacteria: Can New Developments Turn a Troubling Tide?, 12(2) J. BIOLAW & BUS. (2009).

Cody Padgett, Atypical Antipsychotic Drugs Linked to Sudden Death, 12(2) J. BIOLAW & BUS. (2009).

Stanton Stock, Developments in the Treatment of Pneumococcal Infections, 12(2) J. BIOLAW & BUS. (2009).

Regina Dawson, Stem Cells Bring Hope for Multiple Sclerosis Patients, 12(2) J. BIOLAW & BUS. (2009).

Cassandra Wolf, Attempt to Create Stem Cells from Human-Animal Hybrid Fails, 12(2) J. BIOLAW & BUS. (2009).

Whitney Heys, Insulin May Protect Against Alzheimer’s Disease, 12(2) J. BIOLAW & BUS. (2009).

Cody Padgett, FDA Sets Precedent by Listing Oxycontin Abuse Risk in Drug Safety Report, 12(1) J. BIOLAW & BUS. (2009).

Scott K. Peterson, Food Allergies on the Rise in US Children, 12(1) J. BIOLAW & BUS. (2009).

Cassandra Wolf, Potential Health Risks of Over-the-Counter Cough Medications in Children, 12(1) J. BIOLAW & BUS. (2009).

Kathleen Sweeney, Increased Regulation of Energy Drinks Is Necessary to Protect Consmers, 12(1) J. BIOLAW & BUS. (2009).

Matthew LeGrand, Effectiveness of Glucosamine and Chondroitin Sulfate on Knee Osteoarthritis Pain Management and Disease Progression, 12(1) J. BIOLAW & BUS. (2009).

Desiree Nguyen, The Spread of MRSA in Healthcare Facilities, 12(1) J. BIOLAW & BUS. (2009).

Matthew Wheeler, Opportunities for Investment in Preventive Medicine, 12(1) J. BIOLAW & BUS. (2009).

Bryan A. Liang & Tim Mackey, Searching for Safety: Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales, 35 AMERICAN JOURNAL OF LAW & MEDICINE 125 (2009).

James Balcius & Bryan A. Liang, Public Health Law & Military Medical Assets: Legal Issues in Federalizing National Guard Personnel, 18 ANNALS OF HEALTH LAW 35 (2009).

Joya K. Raha, Quarantine, Bioterrorism, and Protecting the Public Health, 11(4) JOURNAL OF BIOLAW & BUSINESS 42 (2008).

Bryan A. Liang, Government Powers in Emergencies: Permitted Actions to Protect the Public's Health, 11(4) JOURNAL OF BIOLAW & BUSINESS 37 (2008).

Bryan A. Liang, Legal and Medical Issues in Emergencies and Disasters, 11(4) JOURNAL OF BIOLAW & BUSINESS 31 (2008).

Bryan A. Liang, Research and Momentum, 11(3) J. BIOLAW & BUS. (2008).

Nicole Wells, $217 Million for Research on Stem Cells in California, 11(3) J. BIOLAW & BUS. (2008).

Erin Minelli, FDA Orders Switch to Inhalers that Do Not Omit CFCs, 11(3) J. BIOLAW & BUS. (2008).

Tim K. Mackey, Climate Ready Genetically Modified Crops, 11(3) J. BIOLAW & BUS. (2008).

Cameron Rhudy, Issues in At-Home Genetic Tests, 11(3) J. BIOLAW & BUS. (2008).

Laura Biddle, Tysabri Approved to Treat Crohn’s Disease, 11(3) J. BIOLAW & BUS. (2008).

Bryan A. Liang, Science and Safety, 11(2) J. BIOLAW & BUS. (2008).

Cameron Rhudy, Abigail Alliance Legal Battle Comes to an End, 11(2) J. BIOLAW & BUS. (2008).

Pamela Willis, Over-the-Counter Adverse Drug Event Reporting, 11(2) J. BIOLAW & BUS. (2008).

Kale Heiman, Lyrica Approved: The First Drug to Treat Fibromyalgia, 11(2) J. BIOLAW & BUS. (2008).

Matthew Izu, MRSA in the Gay and MSM Communities: An Emerging Health Threat, 11(2) J. BIOLAW & BUS. (2008).

Kathleen Sweeney, Beating Heart Created in the Laboratory, 11(2) J. BIOLAW & BUS. (2008).

Nicole Wells, Government Health Officials Begin Cracking Down on Internet Sales of Custom-Mixed Hormones for Menopausal Women, 11(2) J. BIOLAW & BUS. (2008).

Samir Patel, Topical Microbicide to Prevent HIV Infection Fails Clinical Testing, 11(1) J. BIOLAW & BUS. (2008).

Kale Heiman, First Renin-Inhibtor Approved for Hypertension Treatment, 11(1) J. BIOLAW & BUS. (2008).

Jason J. Kennedy, Human Thrombin Approved for Topical Use in Surgery, 11(1) J. BIOLAW & BUS. (2008).

Sasan Mirkarimi, New Drug for Acromegaly Approved, 11(1) J. BIOLAW & BUS. (2008).

Joya K. Raha, Second-Generation Smallpox Vaccine Approved, 11(1) J. BIOLAW & BUS. (2008).

Genevieve A. Suzuki, CDC Survey Reveals Strengths and Weaknesses of U.S. Childhood Immunization, 11(1) J. BIOLAW & BUS. (2008).

Corey P. Hanrahan & Bryan A. Liang, Promoting Public Health and Provider Response to Emergencies and Disasters, 11 UNIVERSITY OF PENNSYLVANIA JOURNAL OF LAW & SOCIAL CHANGE 29 (2008).

Erizen Sei Bowles, French Legislation Disguishes Biosimilar Medicines from Generics, 10(4) J. BIOLAW & BUS. (2007).

Joya Raha, FDA Issues New Safety Information on Erythropoiesis Agents , 10(4) J. BIOLAW & BUS. (2007).

Allison Schneider, HPV Vaccine Mandate Approved in New Mexico, 10(4) J. BIOLAW & BUS. (2007).

Genevieve Suzuki, First Vaccine for Avian Flu Approved , 10(4) J. BIOLAW & BUS. (2007).

Kelly M. Hogan & Bryan A. Liang, Inert Pesticide Ingredient Regulation: Legal and Policy Considerations, 10(3) JOURNAL OF BIOLAW & BUSINESS 14-19 (2007).

Samir Patel, Cancer Rates Drop for Second Straight Year, 10(3) JOURNAL OF BIOLAW & BUSINESS (2007).

Victor J. Herrera, Chronic Disease in Developing Countries: Old Problems for a New Millennium, 10(3) JOURNAL OF BIOLAW & BUSINESS (2007).

Anna Hunter, Mammographic Density: The Risk and Detection of Breast Cancer, 10(3) JOURNAL OF BIOLAW & BUSINESS (2007).

Allison Costain Schneider, EC Lifts Checks on U.S. Corn Gluten, Brewers' Grain, 10(3) JOURNAL OF BIOLAW & BUSINESS (2007).

Joya K. Raha, HHS Contracts $132.5 Million to Develop Adjuvant-Based H5N1 Influenza Vaccines, 10(3) JOURNAL OF BIOLAW & BUSINESS (2007).

Jason Conforti, Tobacco Companies Boosting Nicotine in Cigarettes, 10(3) JOURNAL OF BIOLAW & BUSINESS (2007).

Bryan A. Liang, Research and Results, 10(3) JOURNAL OF BIOLAW & BUSINESS (2007).

Alexis Guanzon, Wal-Mart "Rolls Out" $4 Generic Prescription Drugs, 10(2) JOURNAL OF BIOLAW & BUSINESS (2007).

Aline Gaba, Coronary Drug-Eluting Stents May Cause Death and Myocardial Infarction, 10(2) JOURNAL OF BIOLAW & BUSINESS (2007).

Amber Zupancic, Registered Nurse Safe Staffing Act Addresses Nurse-to-Patient Ratios with Acuity-Based Approach, 10(2) JOURNAL OF BIOLAW & BUSINESS (2007).

Troy B. Krich, CMS New Coverage with Evidence Policy, 10(2) JOURNAL OF BIOLAW & BUSINESS (2007).

Erizen Sei Bowles, Nanotechnology Issues and Challenges, 10(2) JOURNAL OF BIOLAW & BUSINESS (2007).

Joya Raha, First DPP-4 Inhibitor Class Drug for Diabetes Treatment Approved, 10(2) JOURNAL OF BIOLAW & BUSINESS (2007).

Bryan A. Liang, Evidence and Action, 10(2) JOURNAL OF BIOLAW & BUSINESS (2007).

Bryan A. Liang, Costs and Concerns, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

Erizen Sei Bowles, Civil Lawsuits Filed Against Pharmaceutical Companies, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

C.M. Tryon, Fireflies Illuminate Cancer Research, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

Aline Gaba, Study Finds Health Care Spending in the U.S. is Generally Worth the Cost, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

Troy Krich, Health Care Enters the Electronic Age: The Emergence of Health Information Technologies, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

Octavio Cardona-Loya, Medicare to Cut Physician Reimbursements, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

Danielle Gleason, The World Trade Organization Makes a Final Ruling on Genetically Modified Organisms, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

Danielle Gleason, Hwang Woo Suk's Research Shown to be Fabricated, 10(1) JOURNAL OF BIOLAW & BUSINESS (2007).

Erizen Sei Bowles, Counterfeit Tamiflu Seized in U.S., 9(4) JOURNAL OF BIOLAW & BUSINESS (2006).

Andrea G. Fiore, Holograms, RFID Lead the Fight Against Counterfeits in the U.S., 9(4) JOURNAL OF BIOLAW & BUSINESS (2006).

April C. Ness, Proposed Legislation to Combat Counterfeit Pharmaceutical Trafficking in the U.S., 9(4) JOURNAL OF BIOLAW & BUSINESS (2006).

Bart Parsley, Technology and International Cooperation Combat International Drug Trafficking, 9(4) JOURNAL OF BIOLAW & BUSINESS (2006).

Summer Peard, Stronger International Criminal Penalties Proposed for Counterfeiting, 9(4) JOURNAL OF BIOLAW & BUSINESS (2006).

Melanie Porter, Medicare’s Prescription Drug Plan Cuts Down Demand for Individual Drug Imports, 9(4) JOURNAL OF BIOLAW & BUSINESS (2006).

Tim Flanagan, Dogs Aid in Cancer Treatment. 9(3) JOURNAL OF BIOLAW & BUSINESS 46 (2006).

Daniel A. Porras, Advances in Sight Prosthetic May be Limited by Medical Coverage Issues, 9(3) JOURNAL OF BIOLAW & BUSINESS 52 (2006).

Danielle Gleason, Hwang Woo Suk’s Research Shown to be Fabricated, 9(3) JOURNAL OF BIOLAW & BUSINESS (2006).

Aline Gaba, Legislation Encourages Donation of Umbilical Cord Blood to Provide Non-Controversial Stem Cells, 9(3) JOURNAL OF BIOLAW & BUSINESS 54 (2006).

Leslie J. Shields, Enrollment in International HIV/AIDS Study Terminated, 9(3) JOURNAL OF BIOLAW & BUSINESS 56 (2006).

Julie Hall, Biotech Firm Civilly and Criminally Liable for Illegal Promotion of AIDS Drug, 9(3) JOURNAL OF BIOLAW & BUSINESS 48 (2006).

Bart Parsley, Congress Probes Drug Company Grants, 9(3) JOURNAL OF BIOLAW & BUSINESS 50 (2006).

Aurora Elizabeth Bewicke, Pandemics in the Twenty-First Century: China and U.S. Approaches to Quarantine and Isolation. 9(3) JOURNAL OF BIOLAW & BUSINESS 58 (2006).

Amir Alavi. Part D Benefits: Challenges in Implementation. 9(2) JOURNAL OF BIOLAW & BUSINESS 36 (2006).

Joya K. Raha. European Union Members Say No to Marketing Genetically Modified Maize. 9(2) JOURNAL OF BIOLAW & BUSINESS 38 (2006).

Aline Gaba. Legitimacy of Mammograms in Preventing Breast Cancer Deaths. 9(2) JOURNAL OF BIOLAW & BUSINESS 40 (2006).

Emma Bennett-Williams. Africa’s Mass Departure of Medical Professionals. 9(2) JOURNAL OF BIOLAW & BUSINESS 41 (2006).

Nicole Bates & Tiffany Hancock. Inter-Academy Panel Statement of Biosecurity: A Focus on Biological and Toxin Weapons Convention and International Customary Law. 9(2) JOURNAL OF BIOLAW & BUSINESS 43 (2006).

Donna Schuyler & Bryan A. Liang, Reconceptualizing Elder Abuse: Treating the Disease of Senior Community Exclusion, 15(2) ANNALS OF HEALTH LAW 275 (2006).

Laura Lin, Obesity Remains a Global Problem, 9(1) JOURNAL OF BIOLAW & BUSINESS 46 (2006).

Danielle Gleason, FDA Approves New Blood Test to Improve Treatment for Colorectal Cancer, 9(1) JOURNAL OF BIOLAW & BUSINESS 48 (2006).

April C. Ness, National Institutes of Health Enacts Final Ethics Regulations, 9(1) JOURNAL OF BIOLAW & BUSINESS 50 (2006).

Arlene D. Luu, Research Examines the Minimal Risk Standard for Pediatric Research, 9(1) JOURNAL OF BIOLAW & BUSINESS 52 (2006).

Aline Gaba, Face Transplants and the Difficulties of Obtaining Research Approval, 9(1) JOURNAL OF BIOLAW & BUSINESS 54 (2006).

Katherine R. Vick, Stem Cell Research Debate Shifting to the Courts, 9(1) JOURNAL OF BIOLAW & BUSINESS 56 (2006).

Arlene D. Luu & Bryan A. Liang, Clinical Case Management: A Strategy to Coordinate Detection, Reporting, and Prosecution of Elder Abuse, 15(1) CORNELL JOURNAL OF LAW & PUBLIC POLICY 165 (2005).

Laura Lin, Measures Announced to Battle Rising International Counterfeit Drug Production, 8(4) JOURNAL OF BIOLAW & BUSINESS 62 (2005).

Anna M. Dubiak, Generic Industry Pushes for Quicker FDA Review To Reduce Overall Health Care Costs, 8(4) JOURNAL OF BIOLAW & BUSINESS 64 (2005).

Afton Ekemo, Government Support for Embryonic Stem Cell Research, 8(4) JOURNAL OF BIOLAW & BUSINESS 66 (2005).

Arlene D. Luu, The Impact of the HIPAA Privacy Rule on Research Participation, 8(4) JOURNAL OF BIOLAW & BUSINESS 68 (2005).

Eileen N. Nucho, Principal Investigators and Clinical Trials, 8(4) JOURNAL OF BIOLAW & BUSINESS 70 (2005).

Alisa L. Geller, Regulations Limiting Medical Research in Prisons Remains Necessary, 8(4) JOURNAL OF BIOLAW & BUSINESS 72 (2005).

Emma Bennett-Williams, Statin Therapy Underused by African Americans, 8(4) JOURNAL OF BIOLAW & BUSINESS 74 (2005).

Arlene D. Luu & Bryan A. Liang, Case Management: Lessons from Integrated Delivery to Promote Quality Care to the Elderly, 9(2) JOURNAL OF MEDICINE & LAW 257-277 (2005).

Laura Lin & Bryan A. Liang, Reforming Residency: Modernizing Resident Education and Training to Promote Quality and Safety In Health Care, 38(2) JOURNAL OF HEALTH LAW 203-246 (2005).

Laura Lin & Bryan A. Liang, HIV and Health Law: Striking the Balance Between Legal Mandates and Medical Ethics, 7(10) VIRTUAL MENTOR: ETHICS JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (October 2005), available at: http://www.ama-assn.org/ama/pub/category/15549.html.

Lisa M. Smith & Bryan A. Liang, Childhood Obesity: A Public Health Problem Requiring a Policy Solution,9(1) Journal of Medicine & Law. 37-54 (2005).

Bryan A. Liang, Over the Virtual and Geographic Borders: Understanding Importation and Counterfeit Drugs, 36 CALIFORNIA WESTERN INTERNATIONAL LAW JOURNAL 7-18 (2005).

Bryan A. Liang, Introduction: International Drug Importation: Issues in Public Policy, Patient Safety, and the Public Health, 36 CALIFORNIA WESTERN INTERNATIONAL LAW JOURNAL 1-6 (2005).

Bryan A. Liang, "International" Is the Keyword, 8(1) Journal of Biolaw & Business 39 (2005).

Laura A. Willard, Allocating Responsibility for Counterfeit Prescription Drugs, 8(1) Journal of Biolaw & Business 41 (2005).

Lisa M. Smith, The State Challenge of Overturning the Federal Ban of Importing International Prescription Drugs, 8(1) Journal of Biolaw & Business 43 (2005).

Arlene Luu, FDA Recommendations for Antidepressant Use in Children, 8(1) Journal of Biolaw & Business 45 (2005).

Laura Lin, International Stem Cell Use and Regulation in Research, 8(1) Journal of Biolaw & Business 47 (2005).

Moira Brennan, Update on Women and Minority Recruitment in Clinical Trials, 8(1) Journal of Biolaw & Business 49 (2005).

Jannine M. Green, World Health Organization Removes HIV/AIDS Drugs from Prequalification List, 8(1) Journal of Biolaw & Business 50 (2005).

Laura Lin & Bryan A. Liang, Bouvia v Superior Court: Quality of Life Matters, 7(2) VIRTUAL MENTOR: ETHICS JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (February 2005). Available at: http://www.ama-assn.org/ama/pub/category/14474.html.

Laura Lin & Bryan A. Liang, Wright v. Fred Hutchinson Cancer Center: Maintaining patient and public trust in clinical research, 6(11) VIRTUAL MENTOR: ETHICS JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (November 2004). Available at: http://ama-assn.org/ama/pub/category/13189.html.

Bryan A. Liang, The Implications of Research, 8(2) Journal of Biolaw & Business 43 (2005).

Arlene D. Luu, Gene Mutation Found for Parkinson’s Disease, 8(2) Journal of Biolaw & Business 45 (2005).

Laura A. Willard, California Makes Unprecedented Commitment to Fund Stem Cell Research, 8(2) Journal of Biolaw & Business 47 (2005).

Erik Matala, Publishing All Clinical Trial Results May Become Standard Policy, 8(2) Journal of Biolaw & Business 49 (2005).

Elisabeth M.W. Trefonas, Violation of Intellectual Property Agreements May Create Fiduciary Duty and Potential for Punitive Damages, 8(2) Journal of Biolaw & Business 451 (2005).

Laura A. Lin, The U.S. Government Awards First Contract under BioShield Act But Industry Doubts Remain, 8(2) Journal of Biolaw & Business 43 (2005).

Mary E. Grounds-Pérez, Paraguay Officially Approves Genetically Modified Soy Seeds, 8(2) Journal of Biolaw & Business 55 (2005).

Bryan A. Liang, Moving Forward by Releving the Past, 8(3) Journal of Biolaw & Business 46 (2005).

Anna M. Dubiak, Innovative R&D Remains Key To Development of New Prescription Drugs, 8(3) Journal of Biolaw & Business 48 (2005).

Charles Salahuddin, The Effects of Contamination on Stem Cell Research, 8(3) Journal of Biolaw & Business 50 (2005).

Katharine Vick, Judge Declares Pre-Embryo is Human, 8(3) Journal of Biolaw & Business 52 (2005).

Elisabeth M. W. Trefonas, Has the European Union Reopened the Door to Genetically Modified Agricultural Products?, 8(3) Journal of Biolaw & Business 54 (2005).

Laura Lin, FDA Improvements in Drug Safety Monitoring, 8(3) Journal of Biolaw & Business 56 (2005).

Eileen N. Nucho, Bioterrorism Preparedness and Smallpox Vaccination, 8(3) Journal of Biolaw & Business 58 (2005).